Vimarsana
Biggest News Aggregation in the World

Published September News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Published September. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Published September Today - Breaking & Trending Today

Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy - Vimarsana News

Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy

Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.

Source: ajmc.com
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension - Vimarsana News

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 7, 2024--

SGLT2 Inhibitors Could Play a Role in Treating Gout - Vimarsana News

SGLT2 Inhibitors Could Play a Role in Treating Gout

A new review considers how SGLT2 inhibitors like dapagliflozin and empagliflozin have been shown to clinically improve gout while reducing its cardiometabolic and renal comorbidities.

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease -March 13, 2024 at 04:03 am EDT - Vimarsana News

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease -March 13, 2024 at 04:03 am EDT

PREVENAR 20® offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of...

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease | Nation/World - Vimarsana News

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease | Nation/World

NEW YORK--(BUSINESS WIRE)--Mar 13, 2024--